NO20030182D0 - Dermalt påföringssystem for aminolevulinsyre - Google Patents

Dermalt påföringssystem for aminolevulinsyre

Info

Publication number
NO20030182D0
NO20030182D0 NO20030182A NO20030182A NO20030182D0 NO 20030182 D0 NO20030182 D0 NO 20030182D0 NO 20030182 A NO20030182 A NO 20030182A NO 20030182 A NO20030182 A NO 20030182A NO 20030182 D0 NO20030182 D0 NO 20030182D0
Authority
NO
Norway
Prior art keywords
application system
aminolevulinic acid
dermal application
dermal
aminolaevulinic
Prior art date
Application number
NO20030182A
Other languages
English (en)
Other versions
NO20030182L (no
NO330303B1 (no
Inventor
Geoffrey Lee
Rolf-Markus Szeimies
Original Assignee
Photonamic Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonamic Gmbh & Co Kg filed Critical Photonamic Gmbh & Co Kg
Publication of NO20030182L publication Critical patent/NO20030182L/no
Publication of NO20030182D0 publication Critical patent/NO20030182D0/no
Publication of NO330303B1 publication Critical patent/NO330303B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20030182A 2000-07-17 2003-01-14 Dermalt paforingssystem for aminolevulinsyre samt fremgangsmate for fremstilling derav NO330303B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034673A DE10034673C1 (de) 2000-07-17 2000-07-17 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
PCT/EP2001/008131 WO2002005809A1 (de) 2000-07-17 2001-07-13 Dermales applikationssystem für aminolävulinsäure

Publications (3)

Publication Number Publication Date
NO20030182L NO20030182L (no) 2003-01-14
NO20030182D0 true NO20030182D0 (no) 2003-01-14
NO330303B1 NO330303B1 (no) 2011-03-28

Family

ID=7649181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030182A NO330303B1 (no) 2000-07-17 2003-01-14 Dermalt paforingssystem for aminolevulinsyre samt fremgangsmate for fremstilling derav

Country Status (19)

Country Link
US (1) US7951395B2 (no)
EP (1) EP1303267B1 (no)
JP (1) JP4469131B2 (no)
AT (1) ATE263557T1 (no)
AU (2) AU8198001A (no)
CA (1) CA2416147C (no)
CZ (1) CZ299086B6 (no)
DE (2) DE10034673C1 (no)
DK (1) DK1303267T3 (no)
ES (1) ES2215924T3 (no)
HU (1) HU230272B1 (no)
NO (1) NO330303B1 (no)
NZ (1) NZ523798A (no)
PL (1) PL221283B1 (no)
PT (1) PT1303267E (no)
RU (1) RU2262930C2 (no)
TR (1) TR200400865T4 (no)
WO (1) WO2002005809A1 (no)
ZA (1) ZA200210267B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
US8246976B2 (en) * 2004-10-08 2012-08-21 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
DE102011111865A1 (de) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
WO2018185560A2 (en) 2017-04-04 2018-10-11 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
US11131796B2 (en) 2018-09-10 2021-09-28 Texas Instruments Incorporated Optical display with spatial light modulator

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3827561C1 (no) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DK0660712T3 (da) 1992-09-21 2001-08-27 Quadra Logic Tech Inc Transcutation in vivo-aktivering af lysfølsomme midler i blod
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
AU3176695A (en) * 1994-09-20 1996-04-04 Johnson & Johnson Medical, Inc. Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
CA2229285A1 (en) 1995-09-21 1997-03-27 Robert Gurny Nanoparticles in photodynamic therapy
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
NZ533107A (en) 2001-11-08 2007-04-27 Upjohn Co N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
DE10202487A1 (de) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate

Also Published As

Publication number Publication date
US7951395B2 (en) 2011-05-31
RU2262930C2 (ru) 2005-10-27
AU8198001A (en) 2002-01-30
TR200400865T4 (tr) 2004-06-21
EP1303267A1 (de) 2003-04-23
ZA200210267B (en) 2003-06-12
PL221283B1 (pl) 2016-03-31
NO20030182L (no) 2003-01-14
WO2002005809A1 (de) 2002-01-24
JP4469131B2 (ja) 2010-05-26
ATE263557T1 (de) 2004-04-15
CZ2003118A3 (cs) 2003-05-14
EP1303267B1 (de) 2004-04-07
PT1303267E (pt) 2004-07-30
JP2004503591A (ja) 2004-02-05
CA2416147C (en) 2008-11-18
HU230272B1 (hu) 2015-11-30
CZ299086B6 (cs) 2008-04-23
DE10034673C1 (de) 2002-04-25
PL365380A1 (en) 2005-01-10
HUP0301089A3 (en) 2006-07-28
HUP0301089A2 (hu) 2003-09-29
NO330303B1 (no) 2011-03-28
US20050013852A1 (en) 2005-01-20
CA2416147A1 (en) 2002-01-24
NZ523798A (en) 2005-04-29
DK1303267T3 (da) 2004-06-14
DE50101929D1 (de) 2004-05-13
AU2001281980B2 (en) 2006-04-06
ES2215924T3 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
DK1467706T3 (da) Dermalt applikationssystem for aminolevulinsyre-derivater
UY26841A1 (es) Sales estables de ácido o-acetilsalicílico con aminoácidos básicos
ID18145A (id) Asam fosfinik amida sebagai inhibitor metaloprotease matriks
CR6895A (es) Nuevos compuestos heterociclicos su preparacion y su utilizacion como medicamentos en especial como antibacterianos
BR0009762A (pt) Catalisador para produção de ácido acético ou ácido acético e acetato de etila, processo para sua produção e processo para produção de ácido acético ou ácido acético e acetato de etila usando-o
ES2184408T3 (es) Sistema transdermico que contiene un antioxidante.
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
BR0114252A (pt) Derivados de nitrosodifenilamina
NO20030182D0 (no) Dermalt påföringssystem for aminolevulinsyre
NO20013675D0 (no) 2,3,4,5-Tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinaseinhibitorer
EE9900180A (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
BR9907746A (pt) ácidos 2,3,4,5-tetraidro-1h[1,4]-benzodiazepina-3-hidroxâmic os como inibidores de matriz de metaloproteinase
BR0013515A (pt) Inibidores de sintase de ácido graxo
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
ATE242763T1 (de) Methoximinophenylessigsäureamide
BR0207953A (pt) Derivados de caloporosida, processos para a sua preparação e sua aplicação
BR9908511A (pt) Processo para a preparação de um composto, e, composto
PT1100821E (pt) Compostos anti-inflammatorios derivados de lipocortina-1
BR0011537A (pt) Processo para preparar metoxiimino-acetamidas
PT1237850E (pt) Glioxilamidas, processo para a sua preparacao e sua utilizacao para o combate de organismos prejudiciais
HN1997000029A (es) Acido bifenil butirico y sus derivados como inhibidores de metaloproteinasol de matriz.
DK1147095T3 (da) 2,3,4,5-Tetrahydro-1H-[1,4]benzodiazepin-3-hydroxamsyrer som matrixmetalloproteinaseinhibitorer

Legal Events

Date Code Title Description
MK1K Patent expired